Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin

Hormone Research

Volumn 59, Issue 6, 2003, Pages 297-300

  Mizuno, Haruo ^a   Fujimoto, Shinji ^a   Sugiyama, Yukari ^a   Kobayashi, Masanori ^a   Ohro, Yoichiro ^a   Uchida, Shinichi ^b   Sasaki, Sei ^b   Togari, Hajime ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Congenital nephrogenic insipidus; Desmopressin; Thiazide

Indexed keywords

DESMOPRESSIN; THIAZIDE DIURETIC AGENT;

ARTICLE; CASE REPORT; HUMAN; MALE; NEPHROGENIC DIABETES INSIPIDUS; NOCTURIA; PRIORITY JOURNAL; SCHOOL CHILD; SODIUM RESTRICTION; URINE VOLUME;

DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS, NEPHROGENIC; DIURESIS; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALE; RENAL AGENTS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME; TRICHLORMETHIAZIDE; URINATION DISORDERS;

EID: 0037679062     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070629     Document Type: Article

References (12)

1. Reeves WB, Andreoli TE: Nephrogenic diabetes insipidus; in Scriver CR, Beaudel AL, Sly WAS, Valle D (eds): The Metabolic Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 1995, pp 3045-3070.
2. Hoekstra JA, van Lieburg AF, Monnens LA, Hulstijn-Dirkmaat GM, Knoers VV: Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 1996;61:81-88.
3. Monnens L, Jonkman A, Thomas C: Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus. Clin Sci 1984; 66:709-715.
4. Libber S, Harrison H, Spector D: Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 1986; 108:305-311.
5. Rascher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW: Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol 1987; 1:485-490.
6. Moses AM, Scheinman SJ, Oppenheim A: Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin. J Clin Endocrinol Metab 1984;59:1044-1049.
7. Inaba S, Hatakeyama H, Taniguchi N, Miyamori I: The property of a novel V2 receptor mutant in a patient with nephrogenic diabetes insipidus. J Clin Endocrinol Metab 2001;86: 381-385.
8. Crawford DJ, Kennedy GC: Chlorothiazide in diabetes insipidus. Nature 1959;183:891-892.
9. Earley LE, Orloff J: The mechanism of antidiuresis associated with vasopressin-resistant diabetes insipidus. J Clin Invest 1962;41: 1988-1997.
10. Shirley DG, Walter SJ, Laycock JF: The role of sodium depletion in hydrochlorothiazide-induced antidiuresis in Brattleboro rats with diabetes insipidus. Clin Sci Mol Med 1978;54: 209-215.
11. Grønbeck L, Marples D, Nielsen S, Christensen S: Mechanism of antidiuresis caused by bendroflumethiazide in conscious rats with diabetes insipidus. Br J Pharmacol 1998;123: 737-745.
12. Luzius H, Jans DA, Grünbaum EG, Moritz A, Rascher W, Fahrenholz F: A low affinity vasopressin V2 receptor in inherited nephrogenic diabetes insipidus. J Recept Res 1992;12:351-368.